Table 2:

Survey Results: Demographics, Patterns of Drug Use, and experiences with Xylazine

Demographics
Age Range (N=51)		Gender (N=51)		Race (N=50)		Geography (N=50)
Under 20	8%	Male	67%	White, Non-Hispanic	79%	Northeast**	50%
20-29	33%	Female	29%	White, Hispanic	4%	Southeast	14%
30-39	47%	Non-Binary/Other	4%	African American	4%	Midwest	14%
40-49	12%			Asian	5%	Southwest	0%
Over 50	0%			American Indian	4%	West	10%
				Native Hawaiian/Pacific Islander	4%	Other Country*	12%
Patterns of Drug Use
Intentionally seek out to buy drugs that contain xylazine (N=61)		Drug use on a typical day (N=60)		Method of xylazine exposure (N=61)		Frequency of xylazine use (N=61)
Yes	26%	Any Opioids	93%	Inhalational (Smoking)	20%	Daily	39%
No	74%	Fentanyl	80%	Intranasal (Snorting)	57%	1-6 times per week	19%
		Cannabis	45%	Injection	43%	1-4 times per month	15%
		Stimulants	41%	Oral	3%	A few times per year/Rarely	27%
		Benzodiazepines	21%
		Hallucinogens	10%
Experiences with Xylazine
Adverse Effects from xylazine use (N=48)		Have you experienced withdrawal from xylazine? (N=59)		What xylazine withdrawal symptoms have you experienced (N=35)		How has withdrawing from other drugs changed since you started using xylazine? (N=51)
Increased overdoses/passing out	81%	Yes	53%	Body Aches	63%	Worse	57%
Skin Wounds or Infections	43%	No	47%	Cravings	49%	The Same	39%
Increased Emergency Room visits	17%			Anxiety	91%	Better	4%
				Depressed Mood	74%

^*Included 2 responses from the United Kingdom, 2 responses from Canada, 1 response from Sweden, and 1 response from Ecuador.

^**Of the 25 responses that were included from a state in the Northeast, 12 responses were from Pennsylvania